SCHEMBL2467356

SCHEMBL2467356

O=C(NCc1ccc(Oc2ccccc2)cc1)c1ccc(-c2nc(CN(C(=O)c3ccccc3)c3ccc(O)c(C(=O)O)c3)cs2)cc1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 5/20 0.56
PDK1 Q15118 1/20 0.45
KLKB1 P03952 2/20 0.44
PPARA Q07869 1/20 0.44
EIF4E P06730 2/20 0.43
MAPK14 Q16539 3/20 0.42
LMNA P02545 1/20 0.42
CYP3A4 P08684 1/20 0.42
HTT P42858 1/20 0.42
MMP13 P45452 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ALDH1A1 P00352 2/20 0.42
ROCK2 O75116 1/20 0.42
GRK2 P25098 1/20 0.42
HPGD P15428 1/20 0.42
PTGES O14684 1/20 0.42
ALOX5 P09917 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2467885 0.94 STAT3 (0.52) STAT3PDK1KLKB1PPARAEIF4E
SCHEMBL14208388 0.94 STAT3 (0.49) STAT3PDK1KLKB1PPARAEIF4E
SCHEMBL2468824 0.90 STAT3 (0.46) STAT3PDK1KLKB1PPARAEIF4E
SCHEMBL2469846 0.87 STAT3 (0.48) STAT3PDK1KLKB1PPARAEIF4E
SCHEMBL2471982 0.86 STAT3 (0.74) STAT3PDK1PPARAMAPK14LMNA
SCHEMBL2469099 0.83 STAT3 (0.57) STAT3PDK1MAPK14LMNACYP3A4
SCHEMBL2470827 0.81 STAT3 (0.50) STAT3KLKB1PPARAEIF4EALDH1A1
SCHEMBL2469349 0.81 STAT3 (0.52) STAT3EIF4ELMNA
SCHEMBL2468945 0.80 STAT3 (0.51) STAT3KLKB1PPARAEIF4E
SCHEMBL2468218 0.80 STAT3 (0.67) STAT3PDK1MAPK14LMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7365225-B2 Aryl dicarboxamides LABORATOIRES SERONO SA (CH) 2008-04-29 US claimed
US-20060189583-A1 Aryl dicarboxamides MERCK SERONO SA (CH) 2006-08-24 US claimed
EP-1656139-B1 ARYL DICARBOXAMIDES MERCK SERONO SA (CH) 2011-10-05 EP disclosed
US-7365225-B2 Aryl dicarboxamides LABORATOIRES SERONO SA (CH) 2008-04-29 US disclosed
US-20060189583-A1 Aryl dicarboxamides MERCK SERONO SA (CH) 2006-08-24 US disclosed
EP-1656139-A1 ARYL DICARBOXAMIDES Applied Research Systems ARS Holding N.V. (AN) 2006-05-17 EP disclosed
WO-2005011685-A1 ARYL DICARBOXAMIDES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2005-02-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189583-A1 Aryl dicarboxamides GPR119, PTPRS, ECHS1 STAT3 3402/4885PDK1 78/4885KLKB1 3520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.